MPO and Huntington disease: The membrane permeability outcome (MPO) study subsequently showed in its primary outcome that high-flux HD improved survival expectancy of diabetic and hypoalbuminemic HD patients, suggesting a benefit of clearing middle molecular weight uremic compounds69.